Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
biotech
boehringer ingelheim
boston blog main
boston top stories
cancer
deals
eli lilly
new york blog main
new york top stories
pfizer
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
vaccines
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
american cancer society
amgen
apalutamide
atypical hemolytic uremic syndrome
avelumab
big pharma
bill cassidy
biogen
biontech
biovex
boston
boulder/denver blog main
boulder/denver top stories
What
bio
3
×
companies
3
×
pharmaceutical
3
×
cancer
latest
alzheimer’s
approved
bets
combo
comes
cut
date
dating
deal
different
drug
effective
enticed
evidence
fail
game
gene
happening
hasn’t
immunotherapies
increases
kgaa
medications
medicines
merck
messenger
molecules
mrna
multiple
new
oncolytics
pfizer
plan
prescription
price
Language
Current search:
pharmaceutical
×
companies
×
bio
×
@xconomy.com
4 years ago
Oncolytics Bio Tacks On Cancer Combo Study with Merck KGaA, Pfizer
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines